• Clinical and Experimental Pediatrics
• /
• 제50권5호
• /
• pp.457-461
• /
• 2007

목 적 : 요로 감염은 소아에서 흔한 세균성 감염 질환이다. 특히 영아나 어린 소아에서의 감염은 수신증이나 방광 요관 역류와 같은 요로의 동반 기형과 관련성이 높다. 이 연구의 목적은 영아와 어린 소아에서 E. coli 에 의한 요로 감염과 E. coli 외의 다른 균에 의한 요로 감염사이의 임상소견과 검사실 소견, 요로계 영상 검사 소견을 비교해 보는 것이다. 방 법 : 2003년 1월부터 2005년 12월까지 부산 일신 기독 병원 소아과에 요로감염으로 입원한 170명의 환아들의 임상 기록을 후향적으로 분석하였다. 모든 환아들은 E. coli 요로 감염과 non-E. coli 요로 감염의 두 그룹으로 나뉘었고 각각의 인구학적 자료, 임상 자료(발열 정도와 기간, 해열 기간, 입원 기간), 요로계 동반 질환(병력과 초음파를 통해)과 감염의 재발(병력과 과거 의무 기록을 통해), 검사실 소견[요 침사 현미경 검사, 말초혈액 백혈구 수, 적혈구(ESR), CRP, 혈청 크레아티닌 수치]을 비교하였다. 결 과 : 요로 감염으로 진단된 170명의 환아 중 114명(67.1%)은 E. coli에 의한 요로 감염이었고 나머지 56명(32.9%)은 다른 요로 감염 균에 의한 감염이었다. Non-E. coli 그룹은 E. coli 그룹에 비해 발병 연령이 더 낮고($0.52{\pm}0.59$세 vs $0.84{\pm}1.39$세, P<0.05), 요로 기형의 동반률이 높고[46례(82.1%) vs 53례(46.5 %), P<0.001], 재발률이 높고, 해열까지의 기간이 더 짧으며, 말초혈액 백혈구수가 더 적고, CRP 수치가 더 낮고, ESR 수치가 더 낮다. 결 론 : Non-E. coli 요로 감염은 E. coli 요로 감염에 비해 발병 연령이 더 어리고, 경한 임상 양상과 검사실 소견을 보이며, 요로 기형의 동반률이 높고 재발률도 높다.

• 한국동물위생학회지
• /
• 제36권4호
• /
• pp.283-289
• /
• 2013

The antibiotic chemotherapy produces sometimes side effects and fails to eliminate bacterial infection. The occurrence of strains resistant to antibiotics would be expected to increase, and it is nowadays important to search for non-antibiotic substances. We are aimed to evaluate the effects of Torilis fructus extracts against enteropathogenic Escherichia coli (E. coli) in Piglets. The piglets were divided with three groups; Negative control group, E. coli-infected positive control group, and the Torilis fructus extracts treated group with E. coli infection. During the study period, we compared clinical signs, weight increase rate, fecal scores, gross findings between the treated group and non treated group. After necropsy, necropsy findings and histopathological findings were conducted with the comparison between the groups. As the results of this study, the Torilis fructus extracts additive showed the effects on the suppression of E. coli-induced lesions. On the basis of this study results, our data suggest that the Torilis fructus extracts additive have the antimicrobial effects. The Torilis fructus extracts additive could be used as the alternative material for antimicrobial feed additives.

• Childhood Kidney Diseases
• /
• 제10권2호
• /
• pp.192-200
• /
• 2006

Purpose : This study was performed to identify longitudinal changes in the prevalence of organisms isolated from urinary tract infection(UTI) and in the pattern of Escherichia coli susceptibility to antibiotics during the past 10 years in children with UTI. Methods : We performed a retrospective study of a total of 192 urine cultures from children with UTI in the Department of Pediatrics, Seoul Adventist Hospital over two periods(1st: 1995-2000, 2nd:2001-2005). Antimicrobial susceptibility of the isolates was compared between the two groups. Results : The pathogens of UTI in the two groups were similar. In the first period, E. coli was the leading uropathogen(66.2%) followed by Klebsiella pneumoniae(7.8%), Enterobacter cloacae(6.5%), and others(19.5%). In the second period, E. coli was the leading uropathogen(67%) followed by K. pneumoniae(12.2%), E. cloacae(3.5%), Enterobacter aerogenes(3.5%), and others(13.8%). The susceptibility pattern of E. coli to amoxicillin/clavulanate(87.5%, 81.0%) did not present any statistically significant difference between the two periods(P>0.05). The susceptibility of E. coli to TMP/SMX(52.4%, 50.0%) was still low with no significant difference between the two periods(P>0.05). Conclusion : Our results suggest that the use of amoxicillin/clavulanate is still an excellent therapeutic option in children with UTI. The low rate of susceptibility to TMP/SMX against uropathogens suggest that TMP/SMX may be reevaluated as the first-line therapeutic drug for UTI.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
• /
• pp.226.2-226.2
• /
• 2003

The FimH subunit of type 1-fimbriated Escherichia coli has been determined as a major cause of urinary tract infection. To produce a possible vaccine antigen against urinary tract infection, the fimH gene was genetically linked to the Itxa2b gene, which was then cloned into the pMAL -p2E expression vector. The chimaeric construction of pMALfimH/Itxa2b was transformed into Escherichia coli TB1 and its N-terminal amino acid sequence was analyzed. (omitted)

• Childhood Kidney Diseases
• /
• 제23권1호
• /
• pp.29-35
• /
• 2019

Purpose: We aimed to determine characteristics of host, causative organisms, and antibiotic susceptibility of bacteria in pediatric patients with UTI living in metropolitan area of Korea. Methods: Retrospective investigation was done for the causative organisms of UTI in 683 pediatric cases treated at Ajou University Hospital from 2012 to 2017. Patients were classified into Escherichia coli and non-E. coli group, where E. coli group was subdivided into ESBL(+) and ESBL(-) groups based on whether the bacteria could produce extended spectrum beta-lactamase (ESBL). Antibiotic susceptibility of the causative organism was also determined. Results: A total of 683 UTIs occurred in 550 patients, of which 463 (67.8%) were first-time infection and 87 (32.2%) were recurrent ones (2-7 recurrences, 2.52 average), and 64.9% were male and 35.1% were female. The most common causative organism was E. coli (77.2%) and ESBL(+) E. coli was found in 126 cases. The susceptibility of E. coli to 3rd or 4th generation cephalosporin was relatively higher than that to ampicillin or amoxicillin/clavulanic acid. ESBL(+) E. coli showed higher resistance rate to 3rd or 4th generation cephalosporin than ESBL(-) E. coli. Conclusion: New treatment guideline should be considered due to the incidence of ESBL(+) E. coli increased up to one quarter of UTI cases.

• 한국식품위생안전성학회지
• /
• 제32권4호
• /
• pp.336-340
• /
• 2017

본 연구는 정향추출물의 E. coli O157:H7에 대한 항균효과와 E. coli O157:H7 감염 마우스에 대한 치료효과를 평가하기 위해 수행되었다. 정향 메탄올 추출물(FSAE)을 이용하여 E. coli O157:H7에 대한 항균효과 확인 시험을 수행한 결과, 배양 후 24시간째에, FSAE를 첨가한 모든 군들에서 E. coli O157:H7의 생존율이 무투여 대조군에 비해 통계적으로 유의성 있게 감소하는 결과를 보여(0.269 mg/ml, p < 0.05; 0.538과 1.075 mg/ml, p < 0.001), FSAE가 E. coli O157:H7의 증식억제 효과가 뛰어난 것으로 확인되었다. 또한, E. coli O157:H7을 감염시킨 마우스에 FSAE를 경구로 투여한 결과, 투여 후 3일째에, FSAE를 1.075 (p < 0.05)와 2.15 mg/ml (p < 0.01)로 투여한 군들에서 대조군과 비교하여 분변내 E. coli O157:H7의 균수가 유의성 있게 감소하였으며, 투여 7일째에는, 모든 FSAE 투여군들에서 대조군과 비교하여 E. coli O157:H7의 균수가 통계적으로 유의성 있게 감소하였다(0.538 mg/ml, p < 0.05; 1.075와 2.15 mg/ml, p < 0.001). 이상의 연구결과로부터, FSAE를 E. coli O157:H7에 감염된 마우스에 경구로 투여할 경우, 감염증상을 완화 시킬 수 있을 것으로 기대된다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.309.2-309.2
• /
• 2002

The FimH subunit of type l-fimbriated Escherichia coli has been determined as a major cause of urinary tract infection. To produce a possible vaccine antigen against urinary tract infection, the fimH gene was genetically coupled to the ctxa2b gene, which was then cloned into pMAL -p2E expression vector. The chimaeric construction of pMALfimH/ctxa2b was transformed into Escherichia coli TB1 and its N-terminal amino acid sequence was analyzed. (omitted)

• Korean Chemical Engineering Research
• /
• 제56권2호
• /
• pp.240-244
• /
• 2018

There is growing concern about cross infection among the patients to patients, patients to staffs, and tools to patients in healthcare facilities, especially in dentistry. In this study, the most widely used dental impression materials were prepared and the synergy effect of Chlorhexidine and essential oil on antimicrobial activity was examined in the impression materials. Chlorhexidine concentration of 0.1 wt% and 0.5 wt% showed no antimicrobial activity on Escherichia coli (E. coli) and Candida albicans. At 1.0 wt% Chlorhexidine, 0% of E. coli and 34.7% of Candida albicans were survived. Bergamot (Essential oil) concentration of 0.5 wt% and 1.0 wt% showed no antimicrobial activity on E. coli. At 2.0 wt% Bergamot oil, 71.9% of E. coli were survived. Tea tree oil (Essential oil) of 0.5 wt% showed no antimicrobial activity on E. coli. At 1.0 wt% Tea tree oil, 11.2% of E. coli was survived. At 2.0 wt% Tea tree oil, no E. coli was survived. However, no E. coli was survived at the concentration of 0.8 wt% Bergamot with 0.3 wt% Chlorhexidine. At the concentration of 0.8 wt% Tea Tree oil with 0.3 wt% Chlorhexidine, 1.3% of E. coli were survived. The experimental results showed that the synergy effects between Chlorhexidine and essential oils on antimicrobial activity were prominent.

• 대한미생물학회지
• /
• 제35권1호
• /
• pp.41-48
• /
• 2000

Bacteroides fragilis and Escherichia coli, normal colonic inhabitants, are the most frequently isolated bacteria in infected tissues, particularly in intraabdominal abscesses. This study was designed to determine whether enteric bacteria may alter the B. fragilis-induced expression of pro inflammatory cytokines in mouse peritoneal tissue (MPT). After C57BL/6 mice were inoculated with abscess-forming mixture containing B. fragilis in the presence or absence of E. coli, RNA was extracted from MPT. Expression of interleukin (IL)-$1{\alpha}$ and tumor necrosis factor $(TNF){\alpha}$ mRNA was assessed using RT-PCR and standard RNA. Each cytokine protein was also measured by ELISA. The co-inoculation of E. coli into mouse peritoneal cavity advanced the onset of abscess development by B. fragilis infection. When mouse was co-infected with E. coli and B. fragilis intraperitoneally, there was a synergistic increase in the expression of IL-$1{\alpha}$ and $TNF{\alpha}$ mRNA in MPT and this was paralleled by increased cytokine protein secretion. Mixed inoculation of heat-killed E. coli and B. fragilis did not cause a synergistic increase in those cytokine mRNA expression. These results suggest that enteric bacteria may significantly affect proinflammatory cytokine signal produced by host peritoneal cavity in response to B. fragilis infection.

• 한국미생물·생명공학회지
• /
• 제27권5호
• /
• pp.419-425
• /
• 1999

Prophylactic effects of Bifidobacterium longum HY8001, Korean isolate, against Escherichia coli O157:H7 and Salmonella typhimurium DT104 enteric infection were examined at four groups of specific pathogen free(SPF)-ICR mouse for each pathogen. B. longum HY8001+B. typhimurium DT104+B. longum HY8001(BL+ST+BL) group and B. longum HY8001+E. coli O157:H7+B. longum HY8001(BL+E+BL) group were fed with B. longum HY8001 before and after E. coli O157:H7 or s. typhimurium DT104 challenge, while B. longum HY8001+S. typhimurium DT104(BL+ST) and B. longum HY8001+e. coli O157:H7(BL+E) groups were fed with B. longum HY8001 only before E. coli O157:H7 or S. typhimurium DT104 challenge. E. coli O157:H7(E) and S. typhimurium DT104(ST) groups were challenged with each pathogen without B. longum HY8001 administration and control groups were administered with phosphate buffered solution(PBS). After the oral administration with B. longum HY8001(109cfu), th emice were challenged with E. coli O157:H7(2$\times$1010cfu) or S. typhimurium DT104(108cfu) and the mortality rate and the fecal shedding of challenged pathogen were also examined define the reactivity of the B. longum HY8001. Production of toxin neutralizing substance(s) of B. longum HY8001 was determined by cell cytotoxicity assay using Vero cells. Fecal shedding of th eS. typhimurium DT104 was significantly decreased in BL+ST+BL group fed with B. longum HY8--1 before and after challenge(p<0.05), while the fecal shedding s of S. typhimurium DT104 in BL+ST and St groups remained more than 106cfu. the protective effect of the B. longum HY8001 against E. coli O157:H7 was significantly high only in BL+E+BL group fed with b. longum Hy8001 before and after E. coli O157:H7 challenge from the result of fecal E. coli O157:H7 isolation rate, mortality rate, and intestinal contents culture to detect E. coli O157:H7. the mortality rate of the BL+e and E groups. The cytopathic effect (CPE) of the Vero cytotoxin (Shiga like toxin I & II) in Vero cell was neutralized in B. longum HY8001 culture supernatant added wells which indicate the presence of soluble Vero cytotxin neutralizing substance(s) in B. longum HY8001 culture suprnatant.